Cited by 2,020Schizophrenia research and treatmentNeurotransmitter Receptor Influence on BehaviorMental Health and Psychiatry

The DOI matches its Crossref record; 398 of the 399 references it cites were found in a registry or an index.

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

Harrison, P J, Weinberger, D R·2005·Molecular Psychiatry

DOI 10.1038/sj.mp.4001558

Open this paper in CoChat — free account

Abstract

This review critically summarizes the neuropathology and genetics of schizophrenia, the relationship between them, and speculates on their functional convergence. The morphological correlates of schizophrenia are subtle, and range from a slight reduction in brain size to localized alterations in the morphology and molecular composition of specific neuronal, synaptic, and glial populations in the hippocampus, dorsolateral prefrontal cortex, and dorsal thalamus. These findings have fostered the view of schizophrenia as a disorder of connectivity and of the synapse. Although attractive, such concepts are vague, and differentiating primary events from epiphenomena has been difficult. A way forward is provided by the recent identification of several putative susceptibility genes (including neuregulin, dysbindin, COMT, DISC1, RGS4, GRM3, and G72). We discuss the evidence for these and other genes, along with what is known of their expression profiles and biological roles in brain and how these may be altered in schizophrenia. The evidence for several of the genes is now strong. However, for none, with the likely exception of COMT, has a causative allele or the mechanism by which it predisposes to schizophrenia been identified. Nevertheless, we speculate that the genes may all converge functionally upon schizophrenia risk via an influence upon synaptic plasticity and the development and stabilization of cortical microcircuitry. NMDA receptor-mediated glutamate transmission may be especially implicated, though there are also direct and indirect links to dopamine and GABA signalling. Hence, there is a correspondence between the putative roles of the genes at the molecular and synaptic levels and the existing understanding of the disorder at the neural systems level. Characterization of a core molecular pathway and a 'genetic cytoarchitecture' would be a profound advance in understanding schizophrenia, and may have equally significant therapeutic implications.

Integrity signals

Registry

Crossref · 10.1038/sj.mp.4001558

Cites

398 of 398 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
Self-citation
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Amyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., Goldman, D. A., & Weinberger, D. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111134598 · Cited by 2,416
Self-citation
Schizophrenia as a Complex Trait: Evidence From a Meta-analysis of Twin Studies
Sullivan, P. F., Kendler, K. S., & Neale, M. C. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.12.1187 · Cited by 2,356
A review of MRI findings in schizophrenia
Shenton, M. E., Dickey, C. C., Frumin, M., & McCarley, R. W. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00163-3 · Cited by 2,346
Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease
Lohmueller, K. E., Pearce, C. L., Pike, M., Lander, E. S., & Hirschhorn, J. N. (2003) · Nature Genetics · doi:10.1038/ng1071 · Cited by 1,900
Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders
Lachman, H. M., Papolos, D. F., Saito, T., Yu, Y.-M., Szumlanski, C. L., & Weinshilboum, R. M. (1996) · Pharmacogenetics · doi:10.1097/00008571-199606000-00007 · Cited by 1,788
Glutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685
The neuropathology of schizophrenia
Harrison, P. J. (1999) · Brain · doi:10.1093/brain/122.4.593 · Cited by 1,677
Self-citation
Neuregulin 1 and Susceptibility to Schizophrenia
Stefánsson, H., Pétursson, H., Sigurðsson, E., Steinthórsdóttir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., Brynjolfsson, J., Gunnarsdottir, S., Ivarsson, O., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342734 · Cited by 1,671
Meta-analysis of regional brain volumes in schizophrenia
Wright, I. C., Rabe-Hesketh, S., Woodruff, P. W. R., David, A. S., Murray, R. M., & Bullmore, E. T. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.16 · Cited by 1,662
Decreased Dendritic Spine Density on Prefrontal Cortical Pyramidal Neurons in Schizophrenia
Glantz, L. A., & Lewis, D. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.65 · Cited by 1,636
Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease
Botstein, D., & Risch, N. (2003) · Nature Genetics · doi:10.1038/ng1090 · Cited by 1,503
Untitled work
(1995) · PubMed · Cited by 1,320
Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison
Pantelis, C., Velakoulis, D., McGorry, P. D., Wood, S. J., John Suckling, A., Phillips, L., Yung, A. R., Bullmore, E. T., Brewer, W. J., Soulsby, B., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12323-9 · Cited by 1,309
Enzymatic O-methylation of epinephrine and other catechols
Axelrod, J., & Tomchick, R. (1958) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64731-3 · Cited by 1,283
Disruption of two novel genes by a translocation co-segregating with schizophrenia
Millar, J. K. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.9.1415 · Cited by 1,254
Decrease in Reelin and Glutamic Acid Decarboxylase67 (GAD67) Expression in Schizophrenia and Bipolar Disorder
Guidotti, A., Auta, J., Davis, J. M., Gerevini, V. D. G., Dwivedi, Y., Grayson, D. R., Impagnatiello, F., Pandey, G. N., Pesold, C., Sharma, R. P., et al. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.11.1061 · Cited by 1,222
Proteomic analysis of NMDA receptor–adhesion protein signaling complexes
Husi, H., Ward, M. A., Choudhary, J. S., Blackstock, W. P., & Grant, S. G. N. (2000) · Nature Neuroscience · doi:10.1038/76615 · Cited by 1,194
Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia
Hakak, Y., Walker, J. R., Li, C., Wong, W. H., Davis, K. L., Buxbaum, J. D., Haroutunian, V., & Fienberg, A. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081071198 · Cited by 1,192
Kinetics of Human Soluble and Membrane-Bound Catechol O-Methyltransferase: A Revised Mechanism and Description of the Thermolabile Variant of the Enzyme
Lotta, T. I., Vidgren, J., Tilgmann, C., Ulmanen, I., Melén, K., Julkunen, I., & Taskinen, J. (1995) · Biochemistry · doi:10.1021/bi00013a008 · Cited by 1,167
D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor.
Mothet, J., Parent, A., Wolosker, H., Brady, R., Linden, D. J., Ferris, C., Rogawski, M., & Snyder, S. (2000) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.97.9.4926 · Cited by 1,164
GTPase-Activating Proteins for Heterotrimeric G Proteins: Regulators of G Protein Signaling (RGS) and RGS-Like Proteins
Ross, E. M., & Wilkie, T. M. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.795 · Cited by 1,160
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.587 · Cited by 1,141
Genome Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part II: Schizophrenia
Lewis, C. M., Levinson, D. F., Wise, L. H., DeLisi, L. E., Straub, R. E., Hovatta, I., Williams, N. M., Schwab, S. G., Pulver, A. E., Faraone, S. V., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/376549 · Cited by 1,134
Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease
Carlsson, M. L., & Carlsson, A. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90108-m · Cited by 1,086
DNA methylation in health and disease
Robertson, K. D., & Wolffe, A. P. (2000) · Nature Reviews Genetics · doi:10.1038/35049533 · Cited by 1,077
Neuregulins: functions, forms, and signaling strategies
Falls, D. L. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00102-7 · Cited by 1,071
Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors
Männistö, P. T., & Kaakkola, S. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01423-6 · Cited by 1,068
Reversal of Phencyclidine Effects by a Group II Metabotropic Glutamate Receptor Agonist in Rats
Moghaddam, B., & Adams, B. W. (1998) · Science · doi:10.1126/science.281.5381.1349 · Cited by 1,006
Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress
Prabakaran, S., SWATTON, J. E., Ryan, M. M., Huffaker, S. J., Huang, J.-J., Griffin, J. L., Wayland, M. T., Freeman, T., Dudbridge, F., Lilley, K. S., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001511 · Cited by 985
Axonal Neuregulin-1 Regulates Myelin Sheath Thickness
Michailov, G. V., Sereda, M. W., Brinkmann, B. G., Fischer, T. M., Haug, B., Birchmeier, C., Role, L. W., Lai, C., Schwab, M. H., & Nave, K. (2004) · Science · doi:10.1126/science.1095862 · Cited by 940
Oligodendrocyte dysfunction in schizophrenia and bipolar disorder.
Tkachev, D., Mimmack, M., Ryan, M. M., Wayland, M., Freeman, T., Jones, P., Starkey, M., Webster, M., Yolken, R., & Bahn, S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14289-4 · Cited by 940
Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor
Duan, J. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg055 · Cited by 931
Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia
Emamian, E. S., Hall, D., Birnbaum, M. J., Karayiorgou, M., & Gogos, J. A. (2004) · Nature Genetics · doi:10.1038/ng1296 · Cited by 914
The reduced neuropil hypothesis: a circuit based model of schizophrenia
Selemon, L. D., & Goldman-Rakic, P. S. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00281-9 · Cited by 909
Catechol O -methyltransferase val 158 -met genotype and individual variation in the brain response to amphetamine
Mattay, V. S., Goldberg, T. E., Fera, F., Hariri, A. R., Tessitore, A., Egan, M. F., Kolachana, B., Callicott, J. H., & Weinberger, D. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931309100 · Cited by 893
Self-citation
Regulation of Neurotransmitter Release by Metabotropic Glutamate Receptors
Cartmell, J., & Schoepp, D. D. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750889.x · Cited by 883
Molecular Characterization of Schizophrenia Viewed by Microarray Analysis of Gene Expression in Prefrontal Cortex
Mirnics, K., Middleton, F. A., Marquez, A., Lewis, D. A., & Levitt, P. (2000) · Neuron · doi:10.1016/s0896-6273(00)00085-4 · Cited by 882
Prenatal developmental disturbances in the limbic allocortex in schizophrenics
Jakob, H., & Beckmann, H. (1986) · Journal of Neural Transmission · doi:10.1007/bf01249090 · Cited by 875
Linkage strategies for genetically complex traits. II. The power of affected relative pairs.
RISCH, N. J. (1990) · PubMed · Cited by 868
Genetic Variation in the 6p22.3 Gene DTNBP1, the Human Ortholog of the Mouse Dysbindin Gene, Is Associated with Schizophrenia
Straub, R. E., Jiang, Y., MacLean, C. J., Ma, Y., Webb, B. T., Myakishev, M. V., Harris‐Kerr, C., Wormley, B., Sadek, H., Kadambi, B., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/341750 · Cited by 867
The Neurobiology of Slow Synaptic Transmission
Greengard, P. (2001) · Science · doi:10.1126/science.294.5544.1024 · Cited by 865
Catechol- O -methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior
Gogos, J. A., Morgan, M., Luine, V., Santha, M., Ogawa, S., Pfaff, D., & Karayiorgou, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.9991 · Cited by 864
Brain abnormality in schizophrenia
Lawrie, S. M., & Abukmeil, S. S. (1998) · The British Journal of Psychiatry · doi:10.1192/bjp.172.2.110 · Cited by 845
Regionally Localized Thinning of the Cerebral Cortex in Schizophrenia
Kuperberg, G. R., Broome, M. R., McGuire, P. K., David, A. S., Eddy, M., Ozawa, F., Goff, D., West, W. C., Williams, S. C. R., van der Kouwe, A. J. W., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.9.878 · Cited by 843
Genetic and physiological data implicating the new human gene G72 and the gene for d -amino acid oxidase in schizophrenia
Chumakov, I. M., BLUMENFELD, M. L., Guerassimenko, O., Cavarec, L., Palicio, M., Abderrahim, H., Bougueleret, L., Barry, C., Tanaka, H., Rosa, P. L., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182412499 · Cited by 834
Self-citation
Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia
Badner, J. A., & Gershon, E. S. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001012 · Cited by 811
White Matter Changes in Schizophrenia: Evidence for Myelin-Related Dysfunction
Davis, K. L., Stewart, D. G., Friedman, J. I., Buchsbaum, M., Harvey, P. D., Hof, P. R., Buxbaum, J., & Haroutunian, V. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.5.443 · Cited by 793
Neuronal nicotinic receptors in the human brain
Paterson, D., & Nordberg, A. K. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00045-3 · Cited by 792
Regionally localized thinning of the cerebral cortex in schizophrenia
Kuperberg, G. R., Broome, M. R., McGuire, P. K., David, A. S., Eddy, M., Ozawa, F., GOFF, D. C., West, W. C., Williams, S., van der Kouwe, A. J. W., et al. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(03)81127-1 · Cited by 759
Hippocampal Volume Reduction in Schizophrenia as Assessed by Magnetic Resonance Imaging
Nelson, M. D., Saykin, A. J., Flashman, L. A., & Riordan, H. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.5.433 · Cited by 756
Prefrontal neurons and the genetics of schizophrenia
Weinberger, D. R., Egan, M. F., Bertolino, A., Callicott, J. H., Mattay, V. S., Lipska, B. K., Berman, K. F., & Goldberg, T. E. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01252-5 · Cited by 751
Self-citation
Impaired Repression at a 5-Hydroxytryptamine 1A Receptor Gene Polymorphism Associated with Major Depression and Suicide
Lemonde, S., Turecki, G., Bakish, D., Du, L., Hrdina, P. D., Bown, C. D., Sequeira, A., Kushwaha, N., Morris, S. J., Basak, A., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-25-08788.2003 · Cited by 738
DARPP-32: An Integrator of Neurotransmission
Svenningsson, P., Nishi, A., Fisone, G., Girault, J., Nairn, A. C., & Greengard, P. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121415 · Cited by 737
Schizophrenia and Affective Disorders—Cosegregation with a Translocation at Chromosome 1q42 That Directly Disrupts Brain-Expressed Genes: Clinical and P300 Findings in a Family
Blackwood, D., Fordyce, A., Walker, M. T., Clair, D. M. S., Porteous, D. J., & Muir, W. J. (2001) · The American Journal of Human Genetics · doi:10.1086/321969 · Cited by 734
Association within a family of a balanced autosomal translocation with major mental illness
St Clair, D., Blackwood, D., Muir, W., Walker, M., St Clair, D., Muir, W., Carothers, A., Spowart, G., Gosden, C., & Evans, H. J. (1990) · The Lancet · doi:10.1016/0140-6736(90)91520-k · Cited by 727
Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia
Garey, L. J., Ong, W., Patel, T. S., Kanani, M., Davis, A., Mortimer, A. M., Barnes, T., & Hirsch, S. R. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.65.4.446 · Cited by 719
The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications
Harrison, P. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1761-y · Cited by 693
Self-citation
Postnatal neurodevelopmental disorders: meeting at the synapse?
Zoghbi, H. Y. (2003) · Science · doi:10.1126/science.1089071 · Cited by 691
A Highly Significant Association between a COMT Haplotype and Schizophrenia
Shifman, S., Bronstein, M., Sternfeld, M., Pisanté, A., Lev-Lehman, E., Weizman, A., Reznik, I., Spivak, B., Grisaru, N., Karp, L., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/344514 · Cited by 691
Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines
Morón, J. A., Brockington, A., Wise, R. A., Rocha, B. A., & Hope, B. T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00389.2002 · Cited by 681
Altered Distribution of Nicotinamide-Adenine Dinucleotide Phosphate—Diaphorase Cells in Frontal Lobe of Schizophrenics Implies Disturbances of Cortical Development
Akbarian, S. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820150007001 · Cited by 680
Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia
Freedman, R., Hall, M., Adler, L. E., & Leonard, S. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00252-x · Cited by 678
Complexity of Prefrontal Cortical Dysfunction in Schizophrenia: More Than Up or Down
Callicott, J. H., Mattay, V. S., Verchinski, B. A., Marenco, S., Egan, M. F., & Weinberger, D. R. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.12.2209 · Cited by 673
Self-citation
Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins
Weinberger, D. R., Berman, K. F., Suddath, R. L., & Torrey, E. F. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.7.890 · Cited by 669
Self-citation
Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium
Uranova, N. A., Vostrikov, V. M., Orlovskaya, D. D., & Rachmanova, V. I. (2004) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00181-6 · Cited by 659
Schizophrenia as a Disorder of Developmentally Reduced Synaptic Connectivity
McGlashan, T. H. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.7.637 · Cited by 652
A polygenic theory of schizophrenia.
Gottesman, I. I., & Shields, J. (1967) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.58.1.199 · Cited by 636
Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder
Cotter, D. (2002) · Cerebral Cortex · doi:10.1093/cercor/12.4.386 · Cited by 634
An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis
Tokuhiro, S., Yamada, R., Chang, X., Suzuki, A., Kochi, Y., Sawada, T., Suzuki, M., Nagasaki, M., Ohtsuki, M., Ono, M., et al. (2003) · Nature Genetics · doi:10.1038/ng1267 · Cited by 624
A Functional Polymorphism in the COMT Gene and Performance on a Test of Prefrontal Cognition
Malhotra, A. K., Kestler, L. J., Mazzanti, C. M., Bates, J. A., Goldberg, T. E., & Goldman, D. A. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.4.652 · Cited by 623
Genes, dopamine and cortical signal-to-noise ratio in schizophrenia
Winterer, G., & Weinberger, D. R. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.08.002 · Cited by 610
Self-citation
A Unitary Model of Schizophrenia
Andreasen, N. C. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.9.781 · Cited by 609
Genes for schizophrenia? Recent findings and their pathophysiological implications
Harrison, P. J., & Owen, M. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12379-3 · Cited by 597
Self-citation
Genetics of Lactase Persistence and Lactose Intolerance
Swallow, D. M. (2003) · Annual Review of Genetics · doi:10.1146/annurev.genet.37.110801.143820 · Cited by 594
The Regulator of G Protein Signaling Family
Vries, L. D., Zheng, B., Fischer, T., Elenko, E., & Farquhar, M. G. (2000) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.235 · Cited by 592
Schizophrenia as an Anomaly of Development of Cerebral Asymmetry
Crow, T. J. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810120087013 · Cited by 589
Executive Subprocesses in Working Memory
Goldberg, T. E., Egan, M. F., Gscheidle, T., Coppola, R., Weickert, T. W., Kolachana, B. S., Goldman, D. A., & Weinberger, D. R. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.9.889 · Cited by 586
Self-citation
Dopamine Axon Varicosities in the Prelimbic Division of the Rat Prefrontal Cortex Exhibit Sparse Immunoreactivity for the Dopamine Transporter
Sesack, S. R., Hawrylak, V. A., Matus, C., Guido, M. A., & Levey, A. I. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-07-02697.1998 · Cited by 586
The Origin and Neuronal Function ofIn VivoNonsynaptic Glutamate
Baker, D. L., Xi, Z., Shen, H., Swanson, C. J., & Kalivas, P. W. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-20-09134.2002 · Cited by 584
The metabotropic glutamate receptors, MGLUR2 and MGLUR3, show unique postsynaptic, presynaptic and glial localizations
Petralia, R. S., Wang, Y.-X., Niedzielski, A. S., & Wenthold, R. J. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00533-1 · Cited by 580
Glutamatergic mechanisms in schizophrenia
Tsai, G., & Coyle, J. T. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.082701.160735 · Cited by 577
Pronounced Reduction of Total Neuron Number in Mediodorsal Thalamic Nucleus and Nucleus Accumbens in Schizophrenics
Pakkenberg, B. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810230039007 · Cited by 565
From neuropathology to neurodevelopment
Weinberger, D. R. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91386-6 · Cited by 558
Self-citation
Association of Neuregulin 1 with Schizophrenia Confirmed in a Scottish Population
Stefánsson, H., Sarginson, J. E., Kong, A., Yates, P., Steinthórsdóttir, V., Gudfinnsson, E., Gunnarsdottir, S., Walker, N. P., Pétursson, H., Crombie, C., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/345442 · Cited by 555
METHYLATION PHARMACOGENETICS: Catechol O-Methyltransferase, Thiopurine Methyltransferase, and Histamine N-Methyltransferase
Weinshilboum, R. M., Otterness, D. M., & Szumlanski, C. L. (1999) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.19 · Cited by 550
PKB Binding Proteins
Brazil, D. P., Park, J., & Hemmings, B. A. (2002) · Cell · doi:10.1016/s0092-8674(02)01083-8 · Cited by 540
Neuronal and Glial Somal Size in the Prefrontal Cortex: A Postmortem Morphometric Study of Schizophrenia and Huntington Disease
Rajkowska, G., Selemon, L. D., & Goldman-Rakic, P. S. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.3.215 · Cited by 537
Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21
Blouin, J., Dombroski, B. A., Nath, S. K., Lasseter, V. K., Wolyniec, P. S., Nestadt, G., Thornquist, M. H., Ullrich, G., McGrath, J. A., Kasch, L. M., et al. (1998) · Nature Genetics · doi:10.1038/1734 · Cited by 531
NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development
Krystal, J. H., D'Souza, D. C., Mathalon, D., Perry, E., Belger, A., & Hoffman, R. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1582-z · Cited by 530
Some Cytoarchitectural Abnormalities of the Entorhinal Cortex in Schizophrenia
Arnold, S. E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810310043008 · Cited by 523
Location of a Major Susceptibility Locus for Familial Schizophrenia on Chromosome 1q21-q22
Brzustowicz, L. M., Hodgkinson, K. A., Chow, E. W. C., Honer, W. G., & Bassett, A. S. (2000) · Science · doi:10.1126/science.288.5466.678 · Cited by 516
Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: An in situ hybridization study
Ohishi, H., Shigemoto, R., Nakanishi, S., & Mizuno, N. (1993) · The Journal of Comparative Neurology · doi:10.1002/cne.903350209 · Cited by 516
Emerging principles of altered neural circuitry in schizophrenia
Benes, F. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00041-7 · Cited by 513
Neuregulin and ErbB receptor signaling pathways in the nervous system
Buonanno, A., & Fischbach, G. D. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00210-5 · Cited by 505
Electron microscopy of oligodendroglia in severe mental illness
Uranova, N., Orlovskaya, D., Vikhreva, O., Zimina, I., Kolomeets, N., Vostrikov, V., & Rachmanova, V. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00528-7 · Cited by 495
Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia
Miyakawa, T., Leiter, L. M., Gerber, D. J., Gainetdinov, R. R., Sotnikova, T. D., Zeng, H., Caron, M. G., & Tonegawa, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432926100 · Cited by 489
How many diseases does it take to map a gene with SNPs?
Weiss, K. M., & Terwilliger, J. D. (2000) · Nature Genetics · doi:10.1038/79866 · Cited by 479
Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia
Talbot, K., Eidem, W. L., Tinsley, C. L., Benson, M. A., Thompson, E. W., Smith, R. J., Hahn, C.-G., Siegel, S. J., Trojanowski, J. Q., Gur, R. E., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20425 · Cited by 457
A potential vulnerability locus for schizophrenia on chromosome 6p24–22: evidence for genetic heterogeneity
Straub, R. E., MacLean, C. J., O’Neill, F. A., Burke, J. G., Murphy, B. M., Duke, F., Shinkwin, R., Webb, B. T., Zhang, J., Walsh, D., et al. (1995) · Nature Genetics · doi:10.1038/ng1195-287 · Cited by 452
Distorted Distribution of Nicotinamide-Adenine Dinucleotide Phosphate—Diaphorase Neurons in Temporal Lobe of Schizophrenics Implies Anomalous Cortical Development
Akbarian, S. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820150016002 · Cited by 452
Structural Abnormalities in Frontal, Temporal, and Limbic Regions and Interconnecting White Matter Tracts in Schizophrenic Patients With Prominent Negative Symptoms
Sigmundsson, T., Suckling, J., Maier, M., Williams, S., Bullmore, E. T., Greenwood, K., Fukuda, R., Ron, M. A., & Toone, B. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.2.234 · Cited by 452
Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia
Mirnics, K., Middleton, F. A., Stanwood, G. D., Lewis, D. A., & Levitt, P. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000866 · Cited by 446
Association of Promoter Variants in the α7 Nicotinic Acetylcholine Receptor Subunit Gene With an Inhibitory Deficit Found in Schizophrenia
Leonard, S. S., Gault, J., Hopkins, J., Logel, J., Vianzon, R., Short, M., Drebing, C. J., Berger, R., Venn, D., Sirota, P., et al. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.12.1085 · Cited by 443
Glutamate, Dopamine, and Schizophrenia: From Pathophysiology to Treatment
LARUELLE, M., KEGELES, L. S., & ABI‐DARGHAM, A. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.063 · Cited by 437
Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia
Hof, P. R., Haroutunian, V., Friedrich, V. L., Byne, W., Buitron, C., Perl, D. P., & Davis, K. L. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00237-3 · Cited by 433
Catechol-O-Methyltransferase Inhibition Improves Set-Shifting Performance and Elevates Stimulated Dopamine Release in the Rat Prefrontal Cortex
Tunbridge, E. M. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1124-04.2004 · Cited by 423
Neuroimaging studies of the hippocampus in schizophrenia
Heckers, S. (2001) · Hippocampus · doi:10.1002/hipo.1068 · Cited by 420
Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia
Egan, M. F., Straub, R. E., Goldberg, T. E., Yakub, I., Callicott, J. H., Hariri, A. R., Mattay, V. S., Bertolino, A., Hyde, T. M., Weickert, C. S., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405077101 · Cited by 416
Self-citation
Bringing Order to the Glutamate Chaos in Schizophrenia
Moghaddam, B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00757-8 · Cited by 403
Maldistribution of Interstitial Neurons in Prefrontal White Matter of the Brains of Schizophrenic Patients
Akbarian, S. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050061010 · Cited by 397
Lamina-Specific Alterations in the Dopamine Innervation of the Prefrontal Cortex in Schizophrenic Subjects
Akil, M., Pierri, J. N., Whitehead, R. E., Edgar, C. L., Mohila, C., Sampson, A. R., & Lewis, D. A. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.10.1580 · Cited by 396
Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse
Mirnics, K., Middleton, F. A., Lewis, D. A., & Levitt, P. R. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01862-2 · Cited by 395
Differences between smokers and nonsmokers in regional gray matter volumes and densities
Brody, A. L., Mandelkern, M. A., Jarvik, M. E., Lee, G. S., Smith, E. C., Huang, J. C.-S., Bota, R. G., Bartzokis, G., & London, E. D. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00610-3 · Cited by 393
Stress activation of glutamate neurotransmission in the prefrontal cortex: implications for dopamine-associated psychiatric disorders
Moghaddam, B. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01362-2 · Cited by 392
Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies
Scheff, S. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.08.002 · Cited by 391
Disrupted-in-Schizophrenia-1 (DISC-1): Mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth
Ozeki, Y., Tomoda, T., Kleiderlein, J. J., Kamiya, A., Bord, L., Fujii, K., Okawa, M., Yamada, N., Hatten, M. E., Snyder, S. H., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0136913100 · Cited by 388
Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles.
Palmatier, M., Kang, M. A., & Kidd, K. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00098-0 · Cited by 385
DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation
Morris, J. A. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg162 · Cited by 383
Schizophrenia and Glutamatergic Transmission
Tamminga, C. A. (1998) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v12.i1-2.20 · Cited by 382
Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia.
Numakawa, T., Yagasaki, Y., Ishimoto, T., Okada, T., Suzuki, T., Iwata, N., Ozaki, N., Taguchi, T., Tatsumi, M., Kamijima, K., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh280 · Cited by 373
Self-citation
Association and linkage analyses of RGS4 polymorphisms in schizophrenia
Chowdari, K. V. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.12.1373 · Cited by 368
Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function
Matsumoto, M., Weickert, C. S., Akil, M., Lipska, B. K., Hyde, T. M., Herman, M. M., Kleinman, J. E., & Weinberger, D. R. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00556-0 · Cited by 365
Self-citation
Ultrastructural Distribution of the α7 Nicotinic Acetylcholine Receptor Subunit in Rat Hippocampus
Fabian‐Fine, R., Skehel, P., Errington, M. L., Davies, H. A., Sher, E., Stewart, M. G., & Fine, A. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-20-07993.2001 · Cited by 364
Support for Association of Schizophrenia with Genetic Variation in the 6p22.3 Gene, Dysbindin, in Sib-Pair Families with Linkage and in an Additional Sample of Triad Families
Schwab, S. G., Knapp, M., Mondabon, S., Hallmayer, J. F., Borrmann-Hassenbach, M., Albus, M., Lerer, B., Rietschel, M., Trixler, M., Maier, W., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/345463 · Cited by 353
Dopamine transporter immunoreactivity in monkey cerebral cortex: regional, laminar, and ultrastructural localization
Lewis, D. A., Melchitzky, D. S., Sesack, S. R., Whitehead, R. E., Auh, S., & Sampson, A. (2001) · Journal of Comparative Neurology · doi:10.1002/cne.1092 · Cited by 352
Human Dysbindin (DTNBP1) Gene Expression inNormal Brain and in Schizophrenic Prefrontal Cortex and Midbrain
Weickert, C. S., Straub, R. E., McClintock, B., Matsumoto, M., Hashimoto, R., Hyde, T. M., Herman, M. M., Weinberger, D. R., & Kleinman, J. E. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.6.544 · Cited by 352
Self-citation
Magnetic resonance imaging of brain in people at high risk of developing schizophrenia
Lawrie, S. M., Whalley, H. C., Kestelman, J. N., Abukmeil, S. S., Byrne, M., Hodges, A., Rimmington, J. E., Best, J. J. K., Owens, D. G. C., & Johnstone, E. C. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06244-8 · Cited by 351
3‐Methoxytyramine Is the Major Metabolite of Released Dopamine in the Rat Frontal Cortex: Reassessment of the Effects of Antipsychotics on the Dynamics of Dopamine Release and Metabolism in the Frontal Cortex, Nucleus Accumbens, and Striatum by a Simple Two Pool Model
Karoum, F., Chrapusta, S. J., & Egan, M. F. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63030972.x · Cited by 347
Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: differential location relative to pre- and postsynaptic sites
Tamaru, Y., Nomura, S., Mizuno, N., & Shigemoto, R. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00305-0 · Cited by 345
Association Between a Functional Catechol O-Methyltransferase Gene Polymorphism and Schizophrenia: Meta-Analysis of Case-Control and Family-Based Studies
Glatt, S. J., Faraone, S. V., & Tsuang, M. T. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.3.469 · Cited by 343
The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins
Harrison, P. J., Heath, P. R., Eastwood, S. L., Burnet, P. W. J., McDonald, B., & Pearson, R. C. A. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12102-a · Cited by 342
Self-citation
Expression of the dopamine transporter gene is regulated by the 3′ UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR
Mill, J., Asherson, P., Browes, C., D'Souza, U., & Craig, I. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.b.10948 · Cited by 341
N ‐Acetylaspartylglutamate
Neale, J. H., Bzdega, T., & Wróblewska, B. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750443.x · Cited by 341
Oligodendrocytes promote neuronal survival and axonal length by distinct intracellular mechanisms: a novel role for oligodendrocyte-derived glial cell line-derived neurotrophic factor
Wilkins, A., Majed, H., Layfield, R., Compston, A., & Chandran, S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-12-04967.2003 · Cited by 337
Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment
Konradi, C., & Heckers, S. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00328-5 · Cited by 336
A Haplotype Implicated in Schizophrenia Susceptibility Is Associated with Reduced COMT Expression in Human Brain
Bray, N. J., Buckland, P. R., Williams, N. M., Williams, H. J., Norton, N., Owen, M. J., & O’Donovan, M. C. (2003) · The American Journal of Human Genetics · doi:10.1086/376578 · Cited by 335
Genomic organization of the human catechol O‐methyltransferase gene and its expression from two distinct promoters
TENHUNEN, J., SALMINEN, M., LUNDSTRÖM, K., KIVILUOTO, T., SAVOLAINEN, R., & ULMANEN, I. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb19083.x · Cited by 331
The dephosphins: dephosphorylation by calcineurin triggers synaptic vesicle endocytosis
Cousin, M. A., & Robinson, P. J. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01930-5 · Cited by 330
The molecular genetics of schizophrenia: new findings promise new insights
Owen, M. J., Williams, N. M., & O’Donovan, M. C. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001444 · Cited by 328
Catechol- O -Methyltransferase Genotype and Dopamine Regulation in the Human Brain
Akil, M., Kolachana, B. S., Rothmond, D. A., Hyde, T. M., Weinberger, D. R., & Kleinman, J. E. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02008.2003 · Cited by 325
Self-citation
The neuropathology of primary mood disorder
Harrison, P. J. (2002) · Brain · doi:10.1093/brain/awf149 · Cited by 325
Self-citation
Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects
Hennah, W. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg341 · Cited by 325
Neurocognitive correlates of the COMT Val158Met polymorphism in chronic schizophrenia
Bilder, R. M., Volavka, J., Czobor, P., Malhotra, A. K., Kennedy, J. L., Ni, X., GOLDMAN, R. S., Hoptman, M. J., Sheitman, B., Lindenmayer, J., et al. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01416-6 · Cited by 324
Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia
Liu, H., Heath, S. C., Sobin, C., Roos, J. L., Galke, B. L., Blundell, M. L., Lenane, M., Robertson, B., Wijsman, E. M., Rapoport, J. L., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042700699 · Cited by 323
Roles of serine/threonine phosphatases in hippocampel synaptic plasticity
Winder, D. G., & Sweatt, J. D. (2001) · Nature reviews. Neuroscience · doi:10.1038/35081514 · Cited by 320
Single-nucleotide polymorphisms can cause different structural folds of mRNA
Shen, L. X., Basilion, J. P., & Stanton, V. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.7871 · Cited by 319
Disrupted-In-Schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth
Miyoshi, K., Honda, A., Baba, K., Taniguchi, M., Oono, K., Fujita, T., Kuroda, S., Katayama, T., & Tohyama, M. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001352 · Cited by 314
Molecular determinants of metabotropic glutamate receptor signaling
Blasi, A. D., Conn, P. J., Pin, J., & Nicoletti, F. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01635-7 · Cited by 313
Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder
Schumacher, J. H., Jamra, R. A., Freudenberg, J., Becker, T., Ohlraun, S., Otte, A., Tullius, M., Kovalenko, S., Bogaert, A. V. D., Maier, W., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001421 · Cited by 312
Chromosome 1 loci in Finnish schizophrenia families
Ekelund, J. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.15.1611 · Cited by 311
Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions
Arnold, S. E., Franz, B. R., Gur, R. C., Gur, R. E., Shapiro, R. M., Moberg, P. J., & Trojanowski, J. Q. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.5.738 · Cited by 310
Psychiatric Disturbances in Metachromatic Leukodystrophy
Hyde, T. M. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530280095028 · Cited by 308
Reelin-mediated Signaling Locally Regulates Protein Kinase B/Akt and Glycogen Synthase Kinase 3β
Beffert, U., Morfini, G., Bock, H. H., Reyna, H., Brady, S. T., & Herz, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209205200 · Cited by 306
Dysbindin, a Novel Coiled-coil-containing Protein That Interacts with the Dystrobrevins in Muscle and Brain
Benson, M. A., Newey, S. E., Martin‐Rendon, E., Hawkes, R. B., & Blake, D. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010418200 · Cited by 304
Characterization and Implications of Estrogenic Down-Regulation of Human Catechol-O-Methyltransferase Gene Transcription
Xie, T., Ho, S., & Ramsden, D. B. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.31 · Cited by 301
Smoking and mental illness
Leonard, S. S., Adler, L. E., Benhammou, K., Berger, R., Breese, C. R., Drebing, C. J., Gault, J., Lee, M. J., Logel, J., D, A. O. M., et al. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00677-3 · Cited by 298
The gene encoding proline dehydrogenase modulates sensorimotor gating in mice
Gogos, J. A., Sántha, M., Takacs, Z., Beck, K. D., Luine, V. N., Lucas, L., Nadler, J. V., & Karayiorgou, M. (1999) · Nature Genetics · doi:10.1038/7777 · Cited by 296
Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia
Young, K. A., Manaye, K. F., Liang, C., Hicks, P. B., & German, D. C. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00826-x · Cited by 286
Decreased protein level of nicotinic receptor α7 subunit in the frontal cortex from schizophrenic brain
Guan, Z., Zhang, X., Blennow, K., & Nordberg, A. K. (1999) · Neuroreport · doi:10.1097/00001756-199906030-00028 · Cited by 286
Schizophrenia and velo-cardio-facial syndrome
Murphy, K. C. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07604-3 · Cited by 284
Schizophrenia and the brain: a prospective clinico-neuropathological study
Bruton, C. J., Crow, T. J., Frith, C., Johnstone, E. C., Owens, D. G. C., & Roberts, G. W. (1990) · Psychological Medicine · doi:10.1017/s0033291700017608 · Cited by 284
Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia
Hashimoto, R., Straub, R. E., Weickert, C. S., Hyde, T. M., Kleinman, J. E., & Weinberger, D. R. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001434 · Cited by 283
Self-citation
Reduced Neuronal Size in Posterior Hippocampus of Schizophrenic Patients
Benes, F. M., Sorensen, I., & Bird, E. D. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.4.597 · Cited by 279
Pre‐and Postmortem Influences on Brain RNA
BARTON, A. J. L., Pearson, R. C. A., Najlerahim, A., & Harrison, P. J. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03532.x · Cited by 269
Self-citation
Left Hippocampal Volume as a Vulnerability Indicator for Schizophrenia
Seidman, L. J., Faraone, S. V., Goldstein, J. M., Kremen, W. S., Horton, N. J., Makris, N., Toomey, R., Kennedy, D. N., Caviness, V. S., & Tsuang, M. T. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.9.839 · Cited by 263
Polymorphisms at the G72/G30 Gene Locus, on 13q33, Are Associated with Bipolar Disorder in Two Independent Pedigree Series*
Hattori, E., Liu, C., Badner, J. A., Bonner, T. I., Christian, S. L., Maheshwari, M., Detera‐Wadleigh, S. D., Gibbs, R. A., & Gershon, E. S. (2003) · The American Journal of Human Genetics · doi:10.1086/374822 · Cited by 263
Neurotoxicity, Neuroplasticity, and Magnetic Resonance Imaging Morphometry
Weinberger, D. R., & McClure, R. K. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.553 · Cited by 262
Self-citation
Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions
Li, J. Z., Vawter, M. P., Walsh, D. M., Tomita, H., Evans, S. J., Choudary, P. V., Lopez, J. F., Avelar, A., Shokoohi, V., Chung, T., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh065 · Cited by 261
Control of Synaptic Strength, a Novel Function of Akt
Wang, Q., Liu, L., Pei, L., Ju, W. H., Ahmadian, G., Lu, J., Wang, Y., Liu, F., & Wang, Y. T. (2003) · Neuron · doi:10.1016/s0896-6273(03)00356-8 · Cited by 258
GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia
Lewis, D. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00042-9 · Cited by 257
Decreased Somal Size of Deep Layer 3 Pyramidal Neurons in the Prefrontal Cortex of Subjects With Schizophrenia
Pierri, J. N., Volk, C. L. E., Auh, S., Sampson, A., & Lewis, D. A. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.466 · Cited by 257
Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC , encoding the calcineurin gamma subunit
Gerber, D. J., Hall, D., Miyakawa, T., Demars, S., Gogos, J. A., Karayiorgou, M., & Tonegawa, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432927100 · Cited by 256
Subnucleus-specific loss of neurons in medial thalamus of schizophrenics
Popken, G. J., Bunney, W. E., Potkin, S. G., & Jones, E. G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150243397 · Cited by 253
Neuronal Nicotinic Receptors in Dementia with Lewy Bodies and Schizophrenia
COURT, J. A., Spurden, D., Lloyd, S. R., McKeith, I. G., Ballard, C. G., Cairns, N. J., Kerwin, R. W., Perry, R., & Perry, E. K. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731590.x · Cited by 252
Pathology of Layer V Pyramidal Neurons in the Prefrontal Cortex of Patients With Schizophrenia
Black, J. E., Kodish, I. M., Grossman, A. W., Klintsova, A. Y., Orlovskaya, D., Vostrikov, V., Uranova, N., & Greenough, W. T. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.4.742 · Cited by 250
Inheritance of low erythrocyte catechol-o-methyltransferase activity in man.
Weinshilboum, R. M., & Raymond, F. A. (1977) · Europe PMC (PubMed Central) · Cited by 247
A Genome-Wide Scan for Linkage to Chromosomal Regions in 382 Sibling Pairs With Schizophrenia or Schizoaffective Disorder
DeLisi, L. E., Shaw, S. H., Crow, T. J., Shields, G. W., Smith, A., Larach, V. W., Wellman, N. A., Loftus, J., Nanthakumar, B., Razi, K., et al. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.5.803 · Cited by 246
Back signaling by the Nrg-1 intracellular domain
Bao, J., Wolpowitz, D., Role, L. W., & Talmage, D. A. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200212085 · Cited by 241
Association study of neuregulin 1 gene with schizophrenia
Yang, J., M, T., Ruan, Y., Ling, Y. S., Han, Y., Wang, X. L., Zhou, M., Zhang, H. Y., Kong, Q. M., Liu, C., et al. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001377 · Cited by 239
Postmortem Assessment of Thalamic Nuclear Volumes in Subjects With Schizophrenia
Byne, W. M., Buchsbaum, M. S., Mattiace, L. A., Hazlett, E. A., Kemether, E. M., Elhakem, S. L., Purohit, D. P., Haroutunian, V. H., & Jones, L. B. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.59 · Cited by 239
Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia.
Arnold, S. E., Lee, V. M., Gur, R. E., & Trojanowski, J. Q. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10850 · Cited by 236
Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia
Williams, N. M., Preece, A. C., Spurlock, G., Norton, N., Williams, H. J., Zammit, S., O’Donovan, M. C., & Owen, M. J. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001348 · Cited by 234
Polymorphisms in the 3′-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression
Miller, G. M., & Madras, B. K. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4000921 · Cited by 233
Cis-acting variation in the expression of a high proportion of genes in human brain
Bray, N. J., Buckland, P. R., Owen, M. J., & O’Donovan, M. C. (2003) · Human Genetics · doi:10.1007/s00439-003-0956-y · Cited by 232
Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine
Ben-Shachar, D. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01263.x · Cited by 232
Quantification of frontal and temporal lobe brain-imaging findings in schizophrenia: a meta-analysis
Davidson, L. L., & Heinrichs, R. W. (2003) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(02)00118-x · Cited by 232
Structural Brain Abnormalities in Patients With Schizophrenia and Their Healthy Siblings
Staal, W., Pol, H. E. H., Schnack, H. G., Hoogendoorn, M. L. C., Jellema, K. ̄., & Kahn, R. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.3.416 · Cited by 230
Hippocampal Deformities in Schizophrenia Characterized by High Dimensional Brain Mapping
Csernansky, J. G., Wang, L., Jones, D., Rastogi-Cruz, D., Posener, J. A., Heydebrand, G., Miller, J. P., & Miller, M. I. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.12.2000 · Cited by 227
Neural development of the neuregulin receptor ErbB4 in the cerebral cortex and the hippocampus: preferential expression by interneurons tangentially migrating from the ganglionic eminences
Yau, H.-J. (2003) · Cerebral Cortex · doi:10.1093/cercor/13.3.252 · Cited by 225
The origin of schizophrenia: genetic thesis, epigenetic antithesis, and resolving synthesis
Petronis, A. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.005 · Cited by 225
Disrupted in Schizophrenia 1 and Nudel form a neurodevelopmentally regulated protein complex: implications for schizophrenia and other major neurological disorders
Brandon, N. J., Handford, E. J., Schurov, I., Rain, J., Pelling, M., Duran-Jimenez, B., Camargo, L. M., Oliver, K. R., Beher, D., Shearman, M. S., et al. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2003.09.009 · Cited by 224
Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia
Harrison, P. J., & Eastwood, S. L. (2001) · Hippocampus · doi:10.1002/hipo.1067 · Cited by 221
Self-citation
Structural brain imaging in schizophrenia: a selective review
Pearlson, G. D., & Marsh, L. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00071-2 · Cited by 218
The α7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia
Freedman, R., Adams, C. E., & Leonard, S. S. (2000) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(00)00109-5 · Cited by 212
Meta-analysis of thalamic size in schizophrenia
Konick, L. C., & Friedman, L. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00974-4 · Cited by 210

Flagged first, then by citations

1 of the 399 references couldn’t be matched to a known paper.

Research works printed but not linked: 4

Grossman MH, Littrel JB, Weinstein R, Szumlanski C, Weinshilboum R . Identification of the possible basis for inherited differences in human catechol-O-methyltransferase. Trans Neurosci Soc 1992; 18: 70.
Straub RE, Egan MF, Hashimoto R, Matsumoto M, Weickert CS, Goldberg T et al. The schizophrenia susceptibility gene dysbindin (DTNBP1, 6p22.3): analysis of haplotypes, intermediate phenotypes, and alternative transcripts. Biol Psychiatry 2003; 53: 167S.
Callicott JH, Pezeawas L, Egan MF, Hariri AR, Mattay VS, Goldberg TE et al. Genetic variationVariation in DISC-1 affects hippocampal structure and function associated with increased risk for schizophrenia and with normal hippocampal structure and function. (in review).
Toro CT, Kasher PR, Deakin JFW . Altered D-serine metabolism in schizophrenia? A post-mortem study using Stanley Consortium brains [Abstract]. Schizophr Res 2004; 67(Suppl): 125.

Sorted by citations

Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia
Walsh, T., McClellan, J. M., McCarthy, S. E., Addington, A. M., Pierce, S. B., Cooper, G. M., Nord, A. S., Kusenda, M., Malhotra, D., Bhandari, A., et al. (2008) · Science · doi:10.1126/science.1155174 · Cited by 1,800
Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain
Chen, J., Lipska, B. K., Halim, N., Ma, Q. D., Matsumoto, M., Melhem, S., Kolachana, B. S., Hyde, T. M., Herman, M. M., Apud, J., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/425589 · Cited by 1,675
Self-citation
The mismatch negativity: a review of underlying mechanisms
Garrido, M. I., Kilner, J. M., Stephan, K. E., & Friston, K. J. (2009) · Clinical Neurophysiology · doi:10.1016/j.clinph.2008.11.029 · Cited by 1,441
Prenatal Infection and Schizophrenia: A Review of Epidemiologic and Translational Studies
Brown, A. S., & Derkits, E. J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09030361 · Cited by 1,269
NMDA Receptor Hypofunction Produces Opposite Effects on Prefrontal Cortex Interneurons and Pyramidal Neurons
Homayoun, H., & Moghaddam, B. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2213-07.2007 · Cited by 1,231

See all 2,020

Authors: Harrison, P. J., & Weinberger, D. R.
Affiliations: Warneford Hospital (GB)
National Institutes of Health (US)
ORCID: Harrison, P J
Weinberger, D R
Venue: Molecular Psychiatry
Publisher: Springer Science and Business Media LLC
Published: 2004-07-20
Volume: 10
Issue: 1
Pages: 40-68
ISSN: 1359-4184 (ISSN-L)
1476-5578
DOI: 10.1038/sj.mp.4001558
OpenAlex: W2071090720
Cited by: 2,020
References: 399
Citations by year: 2026: 10 · 2025: 20 · 2024: 22 · 2023: 38 · 2022: 38 · 2021: 34 · 2020: 34 · 2019: 42 · 2018: 52 · 2017: 58 · 2016: 66 · 2015: 88 · 2014: 102 · 2013: 92 · 2012: 129
FWCI: 22.22
Type: journal article
Language: en
Update notices: erratum (2005-03-29)
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Molecular Psychiatry (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
Keywords: schizophrenia, schizophrenia genetics, susceptibility genes, gene expression, synaptic plasticity, cortical microcircuitry, NMDA receptor, glutamatergic neurotransmission, dopamine signalling, GABA signalling, neuregulin, dysbindin, catechol-O-methyltransferase, DISC1, RGS4, GRM3, G72, hippocampus, dorsolateral prefrontal cortex, dorsal thalamus, brain connectivity
MeSH terms: Dysbindin, Brain, Carrier Proteins, Catechol O-Methyltransferase, Gene Expression Regulation, Humans, Schizophrenia, Genetic Predisposition to Disease, Neuregulin-1, Dystrophin-Associated Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks